{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:22:53Z","timestamp":1793967773332,"version":"4.8.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ymgme.2025.109270","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:37:48Z","timestamp":1761788268000},"page":"109270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Barth syndrome: Natural history in infants and young children"],"prefix":"10.1016","volume":"146","author":[{"given":"Sharada","family":"Vishwanath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Brockmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Hornby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Reid","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary J.","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109270_bb0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpeds.2019.09.074","article-title":"A Bayesian analysis to determine the prevalence of Barth syndrome in the pediatric population","volume":"217","author":"Miller","year":"2020","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109270_bb0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0022-510X(83)90209-5","article-title":"An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes","volume":"62","author":"Barth","year":"1983","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2025.109270_bb0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ng0496-385","article-title":"A novel X-linked gene, G4.5. is responsible for Barth syndrome","volume":"12","author":"Bione","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2025.109270_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jimd.12422","article-title":"Clinical presentation and natural history of Barth syndrome: an overview","volume":"45","author":"Taylor","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109270_bb0025","series-title":"Barth Syndrome","author":"Ferreira","year":"2020"},{"key":"10.1016\/j.ymgme.2025.109270_bb0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2217\/fca-2023-0008","article-title":"Temporal evolution of the heart failure phenotype in Barth syndrome and treatment with elamipretide","volume":"19","author":"Sabbah","year":"2023","journal-title":"Futur. Cardiol."},{"key":"10.1016\/j.ymgme.2025.109270_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1172-8-23","article-title":"Barth syndrome","volume":"8","author":"Clarke","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109270_bb0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00246-015-1260-z","article-title":"Clinical characteristics and outcomes of cardiomyopathy in Barth syndrome: the UK experience","volume":"37","author":"Kang","year":"2016","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.ymgme.2025.109270_bb0045","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00246-005-0873-z","article-title":"Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome","volume":"26","author":"Spencer","year":"2005","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.ymgme.2025.109270_bb0050","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/gim.2015.204","article-title":"New targets for monitoring and therapy in Barth syndrome","volume":"18","author":"Thompson","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2025.109270_bb0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13023-019-1200-8","article-title":"Understanding the life experience of Barth syndrome from the perspective of adults: a qualitative one-on-one interview study","volume":"14","author":"Mazar","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109270_bb0060","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/ajmg.a.35609","article-title":"The Barth syndrome registry: distinguishing disease characteristics and growth data from a longitudinal study","volume":"158A","author":"Roberts","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2025.109270_bb0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jimd.12453","article-title":"Current and future treatment approaches for Barth syndrome","volume":"45","author":"Thompson","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109270_bb0070","series-title":"Handbook of Mitochondrial Dysfunction","first-page":"61","article-title":"Mitochondrial dysfunction and Barth syndrome","author":"Anzmann","year":"2019"},{"key":"10.1016\/j.ymgme.2025.109270_bb0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MOH.0000000000000472","article-title":"Neutropenia in Barth syndrome: characteristics, risks, and management","volume":"26","author":"Steward","year":"2019","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ymgme.2025.109270_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2021.06.011","article-title":"Neurological & psychological aspects of Barth syndrome: understanding their role and potential impact on quality of life","author":"Olivar-Villanueva","year":"2021","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ymgme.2025.109270_bb0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1750-1172-8-70","article-title":"Natural history of Barth syndrome: a national cohort study of 22 patients","volume":"8","author":"Rigaud","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109270_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1404942","article-title":"Pediatric dilated cardiomyopathy: a review of current clinical approaches and pathogenesis","volume":"12","author":"Malinow","year":"2024","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109270_bb0095","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/fca.13.66","article-title":"Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies","volume":"9","author":"Lipshultz","year":"2013","journal-title":"Futur. Cardiol."},{"key":"10.1016\/j.ymgme.2025.109270_bb0100","series-title":"Illingworth\u2019s the Development of the Infant and Young Child\u202f: normal and Abnormal","author":"Illingworth","year":"2017"},{"key":"10.1016\/j.ymgme.2025.109270_bb0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/ijptr.ijptr_4_22","article-title":"Effectiveness of Peabody developmental motor Scale-2 as an outcome measure: a systematic review","volume":"5","author":"Deshpande","year":"2023","journal-title":"Ind. J. Phys. Ther. Res."},{"key":"10.1016\/j.ymgme.2025.109270_bb0115","series-title":"Peabody Developmental Motor Scales\u2013Third Edition (PDMS-3)","author":"Folio","year":"2023"},{"key":"10.1016\/j.ymgme.2025.109270_bb0120","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1586\/14737167.5.6.705","article-title":"The PedsQL as a pediatric patient-reported outcome: reliability and validity of the PedsQL measurement model in 25,000 children","volume":"5","author":"Varni","year":"2005","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"10.1016\/j.ymgme.2025.109270_bb0125","first-page":"11","article-title":"CDC growth charts for the United States: methods and development","volume":"2002","author":"Kuczmarski","year":"2000","journal-title":"Nat. Cent. Health Stat. Vital Health Stat."},{"key":"10.1016\/j.ymgme.2025.109270_bb0130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1651-2227.2004.tb02974.x","article-title":"Barth syndrome without 3-methylglutaconic aciduria","volume":"93","author":"Schmidt","year":"2004","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2025.109270_bb0135","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajmg.a.61383","article-title":"Delayed appearance of 3-methylglutaconic aciduria in neonates with early onset metabolic cardiomyopathies: a potential pitfall for the diagnosis","volume":"182","author":"Baban","year":"2020","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2025.109270_bb0140","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00431-011-1576-5","article-title":"Barth syndrome diagnosed in the subclinical stage of heart failure based on the presence of lipid storage myopathy and isolated noncompaction of the ventricular myocardium","volume":"170","author":"Takeda","year":"2011","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109270_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.109009","article-title":"Untargeted metabolomics analysis as a potential screening tool for 3-methylglutaconic aciduria syndromes","volume":"144","author":"DiFalco","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109270_bb0150","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cca.2021.08.016","article-title":"Inborn errors of metabolism associated with 3-methylglutaconic aciduria","volume":"522","author":"Jones","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2025.109270_bb0155","first-page":"114","article-title":"Extended recovery of cardiac function after severe infantile cardiomyopathy presentation of Barth syndrome","volume":"63","author":"Yester","year":"2022","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2025.109270_bb0160","article-title":"Expanded-access use of elamipretide in a newborn with Barth syndrome: a case report","volume":"9","author":"Ortmann","year":"2025","journal-title":"Eur. Heart J. Case Rep."},{"key":"10.1016\/j.ymgme.2025.109270_bb0165","first-page":"65","article-title":"Use of Elamipretide in patients assigned treatment in the compassionate use program: case series in pediatric patients with rare orphan diseases","volume":"64","author":"Koenig","year":"2023","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2025.109270_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109220","article-title":"Elamipretide in the Management of Barth Syndrome: current evidence and a case report","volume":"146","author":"Jacob","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109270_bb0175","article-title":"Expanded-access use of elamipretide in a critically ill patient with Barth syndrome","volume":"2","author":"Goldstein","year":"2024","journal-title":"Genet. Med. Open."},{"key":"10.1016\/j.ymgme.2025.109270_bb0180","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1542\/peds.2005-2667","article-title":"Cardiac and clinical phenotype in Barth syndrome","volume":"118","author":"Spencer","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2025.109270_bb0185","article-title":"Stem cell models of TAFAZZIN deficiency reveal novel tissue-specific pathologies in Barth syndrome","author":"Sniezek Carney","year":"2024","journal-title":"Hum. Mol. Genet."},{"issue":"4281\u20134291","key":"10.1016\/j.ymgme.2025.109270_bb0190","article-title":"Phospholipid acyl chain diversity controls the tissue-specific assembly of mitochondrial Cardiolipins","volume":"30","author":"Oemer","year":"2020","journal-title":"Cell Rep."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225002628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225002628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T03:33:01Z","timestamp":1765596781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225002628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1096719225002628"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109270","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barth syndrome: Natural history in infants and young children","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109270"}}